Background The effectiveness of cervical cancer screening programs differs widely in
different populations. The reasons for these differences are unclear. Routine and …

Prophylactic vaccination with human papillomavirus (HPV) virus-like particle (VLP) vaccines
against HPV 16 and HPV 18, which are the cause of 70% or more of cervical cancers in …

Alterations of the Akt/mTOR pathway have been observed in numerous types of cancer, thus
this pathway represents an exciting new target for molecular therapeutics. We investigated …

Background The burden of human papillomavirus (HPV)-associated ano-genital disease is
significant but the ability to generate HPV virus-like particles by the synthesis and self …

OBJECTIVE: To identify the factors associated with regular cervical screening (CS) in the
French female population. METHODS: Face-to-face interviews with 5354 randomly selected …

Detection of specific human papillomavirus (HPV) genotypes, or HPV genotyping, may be
useful for differentiating between those women who are carcinogenic HPV-positive at lower …

Abstract Over the period 1989–2003, the incidence of cervical adenocarcinoma (n= 1615)
was stable whereas that of cervical adenocarcinoma in situ (n= 1884) significantly …

Introducción El marco geográfico autonómico diseña áreas sanitarias en las que se puede
realizar un análisis de salud con el fin de conocer sus necesidades. De acuerdo con ello, se …

It has remained unclear why cervical adenocarcinoma, as observed in consecutive
screening, has rapidly increased during the past decades, while at the same time both that …

Both pre-invasive and invasive cervical glandular lesions remain outstanding challenges.
Although the Australian National Cervical Screening Program has led to an accelerated …